comparemela.com

Page 3 - Ivo Timmermans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer

NIJMEGEN, Netherlands, Sept. 05, 2023 (GLOBE NEWSWIRE) Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment, today

New jerseyUnited statesUnited kingdomSouth africaIvo timmermansHenno welgemoedClinigen groupUniversity of pretoriaPleco therapeutics united states incChief medical officerAcute myeloid leukaemiaSmall cell lung cancerMedical affairsChief executive officerPleco therapeuticsChief medical

Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17 3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU

/PRNewswire/ Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment.

New jerseyUnited statesMichael stalhamerIvo timmermansOndernemend nederlandSue charlesHyloris pharmaceuticals sa euronext brusselsNetherlands enterprise agency rijksdienstRegulatory affairsVp product developmentPleco therapeutics united states incAcute myeloid leukaemiaNetherlands enterprise agencyHyloris pharmaceuticalsEuronext brusselsSmall cell lung cancer

Pleco Therapeutics Closes €17 3M Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesNew jerseyMichael stalhamerIvo timmermansOndernemend nederlandUnited states incHyloris pharmaceuticals sa euronext brusselsRegulatory affairsNetherlands enterprise agency rijksdienstVp product developmentPleco therapeuticsNetherlands enterprise agencyHyloris pharmaceuticalsEuronext brusselsAcute myeloid leukaemiaSmall cell lung cancer

Pleco Therapeutics Announces Expansion with the Incorporation of a U S Subsidiary and the Appointment of Michael Stalhamer as President

/PRNewswire/ Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer promoting cellular.

New yorkUnited statesRutgers universityNew jerseyNew jersey institute of technologyMichael stalhamerIvo timmermansHeritage pharmaceuticalsCollege of engineeringRegulatory affairsJersey institute of technologyPleco therapeutics united states incVp regulatory affairs product developmentVp product developmentAmylin pharmaceuticalsPleco therapeutics united states

Pleco Therapeutics expands into U S and names president

Pleco Therapeutics, a biopharma company based in the Netherlands, has expanded, with a U.S. subsidiary, Pleco Therapeutics USA.

United statesNew jerseyMichael stalhamerIvo timmermansPleco therapeutics united states incPleco therapeuticsPleco therapeutics unitedPleco therapeutics united states

vimarsana © 2020. All Rights Reserved.